Market News

Clifford Swan Investment Counsel Has Lowered Gap Del (GPS) Holding By $4.14 Million; Juno Lighting Has 1.67 Sentiment

Juno Therapeutics, Inc. (NASDAQ:JUNO) Logo

Juno Lighting Inc (JUNO) investors sentiment increased to 1.67 in Q4 2017. It’s up 0.23, from 1.44 in 2017Q3. The ratio is better, as 120 funds increased and started new stock positions, while 72 sold and reduced their equity positions in Juno Lighting Inc. The funds in our database now possess: 68.38 million shares, up from 66.13 million shares in 2017Q3. Also, the number of funds holding Juno Lighting Inc in top ten stock positions increased from 2 to 3 for an increase of 1. Sold All: 25 Reduced: 47 Increased: 75 New Position: 45.

Clifford Swan Investment Counsel Llc decreased Gap Inc. Del (GPS) stake by 55.18% reported in 2017Q4 SEC filing. Clifford Swan Investment Counsel Llc sold 121,775 shares as Gap Inc. Del (GPS)’s stock declined 11.38%. The Clifford Swan Investment Counsel Llc holds 98,905 shares with $3.37 million value, down from 220,680 last quarter. Gap Inc. Del now has $11.87B valuation. The stock increased 1.13% or $0.34 during the last trading session, reaching $30.5. About 264,974 shares traded. The Gap, Inc. (NYSE:GPS) has risen 31.10% since April 17, 2017 and is uptrending. It has outperformed by 19.55% the S&P500.

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell cancer immunotherapies. The company has market cap of $10.10 billion. The firm develops cell cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells. It currently has negative earnings. The Company’s CD19 product candidates include JCAR017 that is in Phase I/II trials for adults with relapsed or refractory B cell aggressive non-Hodgkin lymphoma (NHL) and pediatric patients with r/r B cell acute lymphoblastic leukemia (ALL); JCAR014, which is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies; and JCAR015 that is in Phase II trials for adult patients with r/r ALL.

Sib Llc holds 3.28% of its portfolio in Juno Therapeutics, Inc. for 100,000 shares. Peconic Partners Llc owns 433,587 shares or 2.85% of their US portfolio. Moreover, Cormorant Asset Management Llc has 2.63% invested in the company for 550,000 shares. The Switzerland-based Bb Biotech Ag has invested 2.48% in the stock. Partner Fund Management L.P., a California-based fund reported 1.85 million shares.

It closed at $86.96 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Clifford Swan Investment Counsel Llc increased Mondelez International (NASDAQ:MDLZ) stake by 33,575 shares to 147,412 valued at $6.31M in 2017Q4. It also upped Dxc Technology Co stake by 42,049 shares and now owns 113,840 shares. Verizon Comm. (NYSE:VZ) was raised too.

Analysts await The Gap, Inc. (NYSE:GPS) to report earnings on May, 17. They expect $0.46 EPS, up 27.78% or $0.10 from last year’s $0.36 per share. GPS’s profit will be $179.08 million for 16.58 P/E if the $0.46 EPS becomes a reality. After $0.61 actual EPS reported by The Gap, Inc. for the previous quarter, Wall Street now forecasts -24.59% negative EPS growth.

Since February 1, 2018, it had 1 buy, and 11 selling transactions for $57.85 million activity. 78,325 shares were sold by Chapman Paul Joseph, worth $2.53M. FISHER WILLIAM SYDNEY sold $16.05M worth of stock. $221,701 worth of The Gap, Inc. (NYSE:GPS) was sold by Bazzano Dara. Another trade for 101,820 shares valued at $3.43 million was sold by Kirwan Jeff. Syngal Sonia had sold 28,846 shares worth $954,780. FISHER JOHN J also sold $17.22M worth of The Gap, Inc. (NYSE:GPS) on Tuesday, March 6. FISHER ROBERT J had sold 500,000 shares worth $15.64 million on Tuesday, April 3.

Investors sentiment increased to 0.98 in Q4 2017. Its up 0.02, from 0.96 in 2017Q3. It is positive, as 37 investors sold GPS shares while 153 reduced holdings. 73 funds opened positions while 113 raised stakes. 208.71 million shares or 2.18% more from 204.26 million shares in 2017Q3 were reported. Point72 Asset LP has invested 0.01% in The Gap, Inc. (NYSE:GPS). Moreover, Dnb Asset Mgmt As has 0.01% invested in The Gap, Inc. (NYSE:GPS). Hightower Advsr Ltd has invested 0% in The Gap, Inc. (NYSE:GPS). State Street reported 0.03% in The Gap, Inc. (NYSE:GPS). Korea Inv owns 414,400 shares or 0.06% of their US portfolio. Meag Munich Ergo Kapitalanlagegesellschaft Mbh reported 80,420 shares. Guggenheim Ltd Liability Company accumulated 0.11% or 1.38 million shares. Texas Permanent School Fund invested in 0.03% or 59,448 shares. Northwestern Mutual Wealth Management Communications invested in 15,566 shares or 0% of the stock. Kistler has invested 0.01% in The Gap, Inc. (NYSE:GPS). Campbell & Invest Adviser Limited Liability Com reported 6,292 shares. Bridges Inv Mgmt holds 0.02% of its portfolio in The Gap, Inc. (NYSE:GPS) for 8,000 shares. California State Teachers Retirement System has 0.03% invested in The Gap, Inc. (NYSE:GPS) for 461,515 shares. Hartford Invest Company has 0.03% invested in The Gap, Inc. (NYSE:GPS). Dimensional Fund Ltd Partnership owns 0.04% invested in The Gap, Inc. (NYSE:GPS) for 3.14 million shares.

The Gap, Inc. (NYSE:GPS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *